tetano
Editor, Senior Moderator
Elife
. 2024 Feb 20:13:e85985.
doi: 10.7554/eLife.85985. Transcriptional regulation of SARS-CoV-2 receptor ACE2 by SP1
Hui Han[SUP] #[/SUP][SUP] 1 [/SUP], Rong-Hua Luo[SUP] #[/SUP][SUP] 2 [/SUP], Xin-Yan Long[SUP] #[/SUP][SUP] 2 [/SUP], Li-Qiong Wang[SUP] #[/SUP][SUP] 3 [/SUP], Qian Zhu[SUP] 1 [/SUP], Xin-Yue Tang[SUP] 1 [/SUP], Rui Zhu[SUP] 1 [/SUP], Yi-Cheng Ma[SUP] 1 [/SUP], Yong-Tang Zheng[SUP] 2 [/SUP], Cheng-Gang Zou[SUP] 1 [/SUP]
Affiliations
Angiotensin-converting enzyme 2 (ACE2) is a major cell entry receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The induction of ACE2 expression may serve as a strategy by SARS-CoV-2 to facilitate its propagation. However, the regulatory mechanisms of ACE2 expression after viral infection remain largely unknown. Using 45 different luciferase reporters, the transcription factors SP1 and HNF4α were found to positively and negatively regulate ACE2 expression, respectively, at the transcriptional level in human lung epithelial cells (HPAEpiCs). SARS-CoV-2 infection increased the transcriptional activity of SP1 while inhibiting that of HNF4α. The PI3K/AKT signaling pathway, activated by SARS-CoV-2 infection, served as a crucial regulatory node, inducing ACE2 expression by enhancing SP1 phosphorylation-a marker of its activity-and reducing the nuclear localization of HNF4α. However, colchicine treatment inhibited the PI3K/AKT signaling pathway, thereby suppressing ACE2 expression. In Syrian hamsters (Mesocricetus auratus) infected with SARS-CoV-2, inhibition of SP1 by either mithramycin A or colchicine resulted in reduced viral replication and tissue injury. In summary, our study uncovers a novel function of SP1 in the regulation of ACE2 expression and identifies SP1 as a potential target to reduce SARS-CoV-2 infection.
Keywords: ACE2; SARS-CoV-2; Sp1; infectious disease; microbiology; viruses.
. 2024 Feb 20:13:e85985.
doi: 10.7554/eLife.85985. Transcriptional regulation of SARS-CoV-2 receptor ACE2 by SP1
Hui Han[SUP] #[/SUP][SUP] 1 [/SUP], Rong-Hua Luo[SUP] #[/SUP][SUP] 2 [/SUP], Xin-Yan Long[SUP] #[/SUP][SUP] 2 [/SUP], Li-Qiong Wang[SUP] #[/SUP][SUP] 3 [/SUP], Qian Zhu[SUP] 1 [/SUP], Xin-Yue Tang[SUP] 1 [/SUP], Rui Zhu[SUP] 1 [/SUP], Yi-Cheng Ma[SUP] 1 [/SUP], Yong-Tang Zheng[SUP] 2 [/SUP], Cheng-Gang Zou[SUP] 1 [/SUP]
Affiliations
- PMID: 38375778
- PMCID: PMC10878691
- DOI: 10.7554/eLife.85985
Angiotensin-converting enzyme 2 (ACE2) is a major cell entry receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The induction of ACE2 expression may serve as a strategy by SARS-CoV-2 to facilitate its propagation. However, the regulatory mechanisms of ACE2 expression after viral infection remain largely unknown. Using 45 different luciferase reporters, the transcription factors SP1 and HNF4α were found to positively and negatively regulate ACE2 expression, respectively, at the transcriptional level in human lung epithelial cells (HPAEpiCs). SARS-CoV-2 infection increased the transcriptional activity of SP1 while inhibiting that of HNF4α. The PI3K/AKT signaling pathway, activated by SARS-CoV-2 infection, served as a crucial regulatory node, inducing ACE2 expression by enhancing SP1 phosphorylation-a marker of its activity-and reducing the nuclear localization of HNF4α. However, colchicine treatment inhibited the PI3K/AKT signaling pathway, thereby suppressing ACE2 expression. In Syrian hamsters (Mesocricetus auratus) infected with SARS-CoV-2, inhibition of SP1 by either mithramycin A or colchicine resulted in reduced viral replication and tissue injury. In summary, our study uncovers a novel function of SP1 in the regulation of ACE2 expression and identifies SP1 as a potential target to reduce SARS-CoV-2 infection.
Keywords: ACE2; SARS-CoV-2; Sp1; infectious disease; microbiology; viruses.